Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1151 participants.
Also called NCT01369069
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,151 participants
- Sponsor
- Registry
-
NCT01369069
-
- Main results
- Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial
- Other papers using this trial's data
- Glucose Control and Risk of Symptomatic Intracerebral Hemorrhage Following Thrombolysis for Acute Ischemic Stroke: A SHINE Trial Analysis
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01369069. Randomized; double masking; primary purpose treatment. Start 2012-04 (actual); primary completion 2018-11-19 (actual). Results posted on 2019-12-16.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial
- Acronym
- SHINE
- Condition
- Acute Ischemic Stroke
- Condition
- Diabetes
- Condition
- Hyperglycemia
- Intervention (Drug)
- IV insulin to maintain target glucose concentration of 80-130 mg/dL
- Intervention (Drug)
- Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
- Lead sponsor
- University of Virginia
- Collaborator
- Neurological Emergencies Treatment Trials Network (NETT)
- Collaborator
- Medical University of South Carolina
- Collaborator
- National Institute of Neurological Disorders and Stroke (NINDS)
Record details
- Record id
cardio:ct-nct01369069- Content hash
97d025a8862c63b310720f0eb8fdb2443336d2b3e3ccd8f6b2c0381c3fec96cd